Pembrolizumab in Patients With Microsatellite Instability–High Advanced Endometrial Cancer
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Pembrolizumab in Patients With Microsatellite Instability-High Advanced Endometrial Cancer: Results From the KEYNOTE-158 Study
J. Clin. Oncol 2022 Jan 06;[EPub Ahead of Print], DM O'Malley, GM Bariani, PA Cassier, A Marabelle, AR Hansen, A De Jesus Acosta, WH Miller, T Safra, A Italiano, L Mileshkin, L Xu, F Jin, K Norwood, M MaioFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.